MERKER, Michael, GRAMS, Juliane, KREYENBERG, Hermann, HEIM, Catrin, MOSER, Laura M., WELS, Winfried S., BÖNIG, Halvard, ULLRICH, Evelyn, KLINGEBIEL, Thomas, BADER, Peter und RETTINGER, Eva, [no date]. ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma. Frontiers in immunology. No. Band 11 (2020), Artikel-ID: 581468, p. , Artikel-ID: 581468. DOI 10.3389/fimmu.2020.581468.

Merker, M., Grams, J., Kreyenberg, H., Heim, C., Moser, L.M., Wels, W.S., Bönig, H., Ullrich, E., Klingebiel, T., Bader, P., Rettinger, E., o. J. ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma. Frontiers in immunology , Artikel-ID: 581468. https://doi.org/10.3389/fimmu.2020.581468

Merker, M., Grams, J., Kreyenberg, H., Heim, C., Moser, L. M., Wels, W. S., Bönig, H., Ullrich, E., Klingebiel, T., Bader, P., & Rettinger, E. (o. J.). ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma [Electronic]. Frontiers in immunology, Band 11 (2020), Artikel-ID: 581468, , Artikel-ID: 581468. https://doi.org/10.3389/fimmu.2020.581468

Merker M, Grams J, Kreyenberg H, Heim C, Moser LM, Wels WS, Bönig H, Ullrich E, Klingebiel T, Bader P, Rettinger E ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma. Frontiers in immunology , Artikel-ID: 581468. https://doi.org/10.3389/fimmu.2020.581468

Merker, Michael/ Grams, Juliane/ Kreyenberg, Hermann/ Heim, Catrin/ Moser, Laura M./ Wels, Winfried S./ Bönig, Halvard/ Ullrich, Evelyn/ Klingebiel, Thomas/ Bader, Peter/ Rettinger, Eva, ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma, Frontiers in immunology , , Artikel-ID: 581468.